Diurnal Group PLC Director Dealings and Issue of Equity (3577L)

TIDMDNL

RNS Number : 3577L

Diurnal Group PLC

24 December 2018

24 December 2018

Diurnal Group plc

("Diurnal" or the "Company")

Director Dealings and Issue of equity

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces the issue and allotment of 10,792 ordinary shares of GBP0.05 ("New Ordinary Shares") to John Goddard, Non-Executive Director of the Company.

As published in the Company's AIM Admission Document, on 21 December 2015, and in connection with his recruitment, John Goddard was awarded 32,374 ordinary shares of GBP0.05 each for which Mr Goddard will pay the nominal value for each share ("Conditional Shares"). The award of Conditional Shares vested in thirds 18, 24 and 36 months from 24 December 2015, being the date of admission to AIM. There are no other performance criteria and all Conditional Shares have now vested.

John Goddard's interest in the Company is now as follows:

 
 Name            Position                 Total number of Conditional Shares     Total number of ordinary shares now 
                                          now held                               held 
                ------------------------ 
 John Goddard    Non-Executive Director   Nil                                    53,993 
                ------------------------                                         ------------------------------------- 
 

Application has been made for admission of the New Ordinary Shares to trading on AIM, which is anticipated to occur at 8:00am on 31 December 2018 ("Admission"). The New Ordinary Shares will rank pari passu with the existing shares of common stock of the Company. Following Admission, the Company's issued ordinary share capital will consist of 61,710,858 ordinary shares. The Company does not hold any shares in treasury. Therefore, the total number of ordinary shares with voting rights in Diurnal following Admission will be 61,710,858.

The above figure of 61,710,858 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 
 For further information, please visit www.diurnal.co.uk or contact: 
 
                                                       [phone] 
 Diurnal Group plc                                      1000 
 Martin Whitaker, Chief Executive Officer 
 Richard Bungay, Chief Financial Officer 
 
 Panmure Gordon (UK) Limited (Nominated Adviser        [phone] 
  and Joint Broker)                                     2500 
 Corporate Finance: Freddy Crossley, Emma Earl 
 Corporate Broking: James Stearns 
 
                                                       [phone] 
 Cantor Fitzgerald Europe (Joint Broker)                7000 
 Corporate Finance: Phil Davies, Will Goode, 
  Michael Boot 
 Healthcare Equity Sales: Andrew Keith 
 
                                                       [phone] 
 FTI Consulting (Media and Investor Relations)          1000 
 Simon Conway 
 Victoria Foster Mitchell 
 

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visit www.diurnal.co.uk

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCAs") with them.

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                    John Goddard 
      -------------------------------------  ----------------------------------------------- 
 2     Reason for the notification 
      -------------------------------------------------------------------------------------- 
 a)    Position/status                        Non-Executive Director 
      -------------------------------------  ----------------------------------------------- 
 b)    Initial notification                   Initial notification 
        /Amendment 
      -------------------------------------  ----------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      -------------------------------------------------------------------------------------- 
 a)    Name                                   Diurnal Group plc 
      -------------------------------------  ----------------------------------------------- 
 b)    LEI                                    213800I2HNUNZN1LDH29 
      -------------------------------------  ----------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      -------------------------------------------------------------------------------------- 
 a)    Description of the                     Ordinary shares of 5p each 
        financial instrument, 
        type of instrument 
 
       Identification code                    GB00BDB6Q760 
 
 b)    Nature of the transaction              Exercise of options over ordinary shares 
      -------------------------------------  ----------------------------------------------- 
 c)    Price(s) and volume(s) 
                                              ----------------------  -------------------- 
                                               Price(s)                Volume(s) 
                                              ----------------------  -------------------- 
    GBP539.60                                                          10,792 
   -----------------------------------------------------------------  -------------------- 
 
 d)    Aggregated information 
 
  - Aggregated volume                    10,792 
 
  - Price                                GBP0.05 
 
 e)    Date of the transaction                24 December 2018 
      -------------------------------------  ----------------------------------------------- 
 f)    Place of the transaction               Off Market 
      -------------------------------------  ----------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHLLFESFRLVFIT

(END) Dow Jones Newswires

December 24, 2018 02:00 ET (07:00 GMT)